Literature DB >> 23296582

Pregnancy and isotretinoin therapy.

June Seek Choi1, Gideon Koren, Irena Nulman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23296582      PMCID： PMC3602257          DOI： 10.1503/cmaj.120729

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  17 in total

1.  Accutane registry compulsory in US, but not Canada.

Authors:  Margot Andresen
Journal:  CMAJ       Date:  2006-06-06       Impact factor: 8.262

2.  Pharmacokinetics of oral isotretinoin.

Authors:  U W Wiegand; R C Chou
Journal:  J Am Acad Dermatol       Date:  1998-08       Impact factor: 11.527

3.  Continued occurrence of Accutane-exposed pregnancies.

Authors:  M A Honein; L J Paulozzi; J D Erickson
Journal:  Teratology       Date:  2001-09

4.  Prescriptions, power and politics: the turbulent history of methadone maintenance in Canada.

Authors:  B Fischer
Journal:  J Public Health Policy       Date:  2000       Impact factor: 2.222

5.  Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.

Authors:  Allen Brinker; Cynthia Kornegay; Parivash Nourjah
Journal:  Arch Dermatol       Date:  2005-05

6.  A survey of pregnant women using isotretinoin.

Authors:  Julia Robertson; Janine E Polifka; Marina Avner; Christina Chambers; George Delevan; Gideon Koren; Sharon Voyer Lavigne; Lynn P Martinez; Richard K Miller; John C Carey
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2005-11

7.  Use of the Retinoid Pregnancy Prevention Program in Canada: patterns of contraception use in women treated with isotretinoin and etretinate.

Authors:  A Pastuszak; G Koren; M J Rieder
Journal:  Reprod Toxicol       Date:  1994 Jan-Feb       Impact factor: 3.143

8.  Steady-state pharmacokinetics of isotretinoin and its 4-oxo metabolite: implications for fetal safety.

Authors:  I Nulman; M Berkovitch; J Klein; A Pastuszak; R S Lester; N Shear; G Koren
Journal:  J Clin Pharmacol       Date:  1998-10       Impact factor: 3.126

9.  Retinoic acid embryopathy.

Authors:  E J Lammer; D T Chen; R M Hoar; N D Agnish; P J Benke; J T Braun; C J Curry; P M Fernhoff; A W Grix; I T Lott
Journal:  N Engl J Med       Date:  1985-10-03       Impact factor: 91.245

10.  A pregnancy-prevention program in women of childbearing age receiving isotretinoin.

Authors:  A A Mitchell; C M Van Bennekom; C Louik
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245
View more
  10 in total

Review 1.  [Dermatological topical and systemic therapy during pregnancy].

Authors:  S Grunewald; P Staubach
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

2.  Pregnancy and isotretinoin therapy.

Authors:  June Seek Choi; Gideon Koren; Irena Nulman
Journal:  CMAJ       Date:  2013-04-02       Impact factor: 8.262

3.  Pregnancy and isotretinoin therapy.

Authors:  Tania Dumont; Amanda Black
Journal:  CMAJ       Date:  2013-04-02       Impact factor: 8.262

4.  Patients' Knowledge and Information Needs about Isotretinoin Therapy Use in Jordan.

Authors:  Anan S Jarab; Sayer Al-Azzam; Shriefa Almutairi; Tareq L Mukattash
Journal:  Int J Clin Pract       Date:  2022-02-14       Impact factor: 3.149

5.  Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy.

Authors:  David Henry; Colin Dormuth; Brandace Winquist; Greg Carney; Shawn Bugden; Gary Teare; Linda E Lévesque; Anick Bérard; J Michael Paterson; Robert W Platt
Journal:  CMAJ       Date:  2016-04-25       Impact factor: 8.262

Review 6.  Nanoparticles in pregnancy: the next frontier in reproductive therapeutics.

Authors:  Natasha Pritchard; Tu'uhevaha Kaitu'u-Lino; Lynda Harris; Stephen Tong; Natalie Hannan
Journal:  Hum Reprod Update       Date:  2021-02-19       Impact factor: 17.179

7.  Washout Period for Pregnancy Post Isotretinoin Therapy.

Authors:  Hina Jajoria; Venkataram Mysore
Journal:  Indian Dermatol Online J       Date:  2020-03-09

8.  Using Natural Language Processing to Examine the Uptake, Content, and Readability of Media Coverage of a Pan-Canadian Drug Safety Research Project: Cross-Sectional Observational Study.

Authors:  Hossein Mohammadhassanzadeh; Ingrid Sketris; Robyn Traynor; Susan Alexander; Brandace Winquist; Samuel Alan Stewart
Journal:  JMIR Form Res       Date:  2020-01-14

9.  Isotretinoin Treatment Practices and Outcomes in Acne Patients During the COVID-19 Pandemic: A Single Center, Retrospective, Comparative Study.

Authors:  Mehmet Fatih Atak; Banu Ismail Mendi; Incilay Kalay Yildizhan; Hatice Sanli; Banu Farabi
Journal:  Dermatol Pract Concept       Date:  2022-01-01

10.  Awareness of isotretinoin use and Saudi FDA pregnancy prevention program in Riyadh, Saudi Arabia: A cross-sectional study among female patients.

Authors:  Alnada Abdalla Mohamed Ibrahim; Amal Almotiry Alshatri; Salem Alsuwaidan; Lulu Almutairi; Nasser Aljasser; Mansour Adam Mahmoud; Afnan Alaseeri; Abrar Almonysir; Badraa Alotaibi; Batoul Alrasheed; Maram Alfawaz
Journal:  Saudi Pharm J       Date:  2021-04-23       Impact factor: 4.330
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.